In Vivo Genome Engineering for the Treatment of Muscular Dystrophies

被引:0
作者
Monika Kustermann
Matthew J. Rok
Ronald D. Cohn
Evgueni A. Ivakine
机构
[1] Peter Gilgan Centre for Research and Learning,Program in Genetics and Genome Biology
[2] The Hospital for Sick Children Research Institute,Department of Molecular Genetics
[3] University of Toronto,Department of Pediatrics
[4] The Hospital for Sick Children,Institute of Medical Science
[5] University of Toronto,Department of Physiology
[6] University of Toronto,undefined
来源
Current Stem Cell Reports | 2020年 / 6卷
关键词
Muscular dystrophy; Duchenne muscular dystrophy; Genome editing; CRISPR/Cas9; Adeno-associated viruses; Nanoparticles;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:52 / 66
页数:14
相关论文
共 799 条
[51]  
Díaz-Manera J(2018)Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy Science. 362 86-1585
[52]  
Gallardo E(2019)CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells Sci Adv 5 eaav4324-130
[53]  
Karaduman AA(2019)In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse Nat Commun 10 4537-490
[54]  
Topaloğlu H(2020)Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy Nat Med 26 207-1388
[55]  
el Sherif R(2020)Challenges associated with homologous directed repair using CRISPR-Cas9 and TALEN to edit the DMD genetic mutation in canine Duchenne muscular dystrophy PLoS One 15 e0228072-189
[56]  
Stringer A(2020)Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system Sci Adv 6 eaay6812-255
[57]  
Shatillo AV(2020)Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping Nat Commun 11 1334-220
[58]  
Martin AS(2019)Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy Nat Med 25 427-217
[59]  
Peay HL(2019)Life-long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice Mol Ther 27 1407-259
[60]  
Bellgard MI(2019)AAV9 edits muscle stem cells in normal and dystrophic adult mice Mol Ther 27 1568-1171